Search Results 1981-1990 of 2911 for site:slotspk17.com

1. Define in Humans With Compensated CHF and Renal Dysfunction, the Modulating Action of Chronic AT1 Receptor Blockade in Addition to ACE Inhibition on Cardiorenal and Humoral Function - Mayo Clinic

   Define in Humans With Compensated CHF and Renal Dysfunction, the Modulating Action of Chronic AT1 Receptor Blockade in Addition to ACE Inhibition on Cardiorenal ...

2. Multimodal Biomarkers to Identify a Lewy Body Disease Neurodegeneration Index - Mayo Clinic

   The purpose of this study is to pilot test a novel Lewy body disease neurodegeneration index from Neuropacs in patients with PD & cognitive impairment. To pilot ...

3. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

   The OLE period is intended to allow each patient at least 1 year of treatment with open-label benralizumab 30 mg administered SC every 4th week (earlier ...

4. Opioid Use After PCNL - Clinical Trials

   About this study. The purpose of the study is to assess patients' use of opioid and non-opioid pain medication following percutaneous nephrolithotomy, ...

5. A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain

   About this study. The study hypotheses is that the proportion of patients experiencing clinically significant pain relief will be at least 30% greater than ...

6. Diagnostic 68Ga-PSMA-11 PET/CT - Clinical Trials

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT) - Mayo Clinic

   A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT).

8. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

   The purpose of this study is to confirm that levosimendan can significantly improve respiratory function measured by supine slow vital capacity (SVC) in ...

9. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

   The purpose of this study is to evaluate the safety and effectiveness of iloprost on the frequency of and relief from symptomatic digital ischemic episodes in ...

10. A Study to Evaluate the Effectiveness and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy - Mayo Clinic

    The purpose of this study is to evaluate vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. Participation eligibility. Participant ...